We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
CEMIG Preferred Shares
CIG
$5.52B
| – | – |
-2,683,686
| Closed | -$6.41M | – |
|
3202
Chimera Investment
CIM
$702M
| – | – |
-116,565
| Closed | -$1.46M | – |
|
3203
Cincinnati Financial
CINF
$27.8B
| – | – |
-206,614
| Closed | -$32.5M | – |
|
3204
Cingulate
CING
$80.4M
| – | – |
-92,934
| Closed | -$577K | – |
|
3205
Core Laboratories
CLB
$474M
| – | – |
-117,744
| Closed | -$1.98M | – |
|
3206
Cellebrite
CLBT
$3B
| – | – |
-146,904
| Closed | -$2.02M | – |
|
3207
Cellectis
CLLS
$106M
| – | – |
-41,112
| Closed | -$130K | – |
|
3208
ClearPoint Neuro
CLPT
$296M
| – | – |
-52,259
| Closed | -$476K | – |
|
3209
Clarivate
CLVT
$1.16B
| – | – |
-1,343,271
| Closed | -$3.4M | – |
|
3210
Commercial Metals
CMC
$7.02B
| – | – |
-19,341
| Closed | -$1.19M | – |
|
3211
CALL
Comcast
CMCSA
$77.6B
| – | – |
-100
| Closed | -$2.87K | – |
|
3212
CALL
Cummins
CMI
$73B
| – | – |
-200
| Closed | -$108K | – |
|
3213
CALL
Centene
CNC
$33.9B
| – | – |
-24,300
| Closed | -$796K | – |
|
|
3214
PUT
Centene
CNC
$33.9B
| – | – |
-924,100
| Closed | -$30.3M | – |
|
3215
CenterPoint Energy
CNP
$27.6B
| – | – |
-152,285
| Closed | -$6.57M | – |
|
|
CNTA
3216
DELISTED
Centessa Pharmaceuticals
CNTA
| – | – |
-168,177
| Closed | -$6.68M | – |
|
3217
Z Squared Inc
ZSQR
$231M
| – | – |
-24,513
| Closed | -$275K | – |
|
3218
PUT
Coherent
COHR
$46.4B
| – | – |
-230,000
| Closed | -$54.8M | – |
|
3219
CALL
Vistance Networks Inc
VISN
$1.51B
| – | – |
-14,900
| Closed | -$271K | – |
|
3220
Chesapeake Utilities
CPK
$3.4B
| – | – |
-4,732
| Closed | -$598K | – |
|
3221
CPS Technologies
CPSH
$70.4M
| – | – |
-72,615
| Closed | -$272K | – |
|
3222
California Resources
CRC
$4.81B
| – | – |
-35,100
| Closed | -$2.43M | – |
|
3223
Crawford & Co Class B
CRD.B
$578M
| – | – |
-27,982
| Closed | -$284K | – |
|
3224
PUT
Credo Technology Group
CRDO
$31.5B
| – | – |
-210,000
| Closed | -$19.7M | – |
|
3225
Crescent Energy
CRGY
$5.78B
| – | – |
-16,390
| Closed | -$221K | – |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.